tiprankstipranks
pc:belit

Belite Bio

Belite Bio, Inc is a clinical-stage drug development company dedicated to creating novel therapeutics for degenerative retinal diseases with significant unmet medical needs, such as Stargardt disease and geographic atrophy in advanced dry age-related macular degeneration. The company is also involved in developing treatments for specific metabolic diseases, leveraging its expertise in RBP4 inhibition as a mechanism of action.

Leadership & Board

Currently, no data available

Latest Estimated Valuation

Estimated Valuation
Estimated Valuation
Total Amount Raised$125M
Total Amount Raised$125M
Total Funding Rounds1
Total Funding Rounds1
Latest Funding Amount$125M
Latest Funding Amount$125M
Latest Funding RoundInvestment
Latest Funding RoundInvestment
Post-Money Valuation
Post-Money Valuation

Funding Round

Funding Date
Funding Round
Amount Raised
Post-Money Valuation
Sep 08, 2025
Investment
$125.00M

Investors

Investor Name
Funding Round

Related News and Analysis